discovery of the genetic map of skin cancer and lung

Won a major scientific discovery by British scientists have great interest in leading British newspapers today, Thursday, and boils down to this discovery in determining the genetic map of two of the most deadly cancers, which is described by the Telegraph newspaper that opens the door to a new era for the treatment of these diseases.

The Telegraph says that all mutations or mutations which prevent healthy cells in both skin and lung cancer have been identified as the researchers called a moment of transition in the research of prevention and treatment of both diseases are killers. And will lead the detailed picture of the main reasons for this disease to early detection, and then access to new varieties of drugs and a better understanding of the causes of disease as scientists say.

The researchers say a simple blood test can be determined on the basis of choice of treatment, which can recognize the attack and kill the reasons that lead to cancer on an individual basis.

The paper quotes Professor Mike Stratton who led the research at the Institute of Sanger Wilcke Foundation Trust of Cambridge, which had sponsored and funded the research, said: “What we see today will change the way we deal with cancer.”

And mapping scientists the genetic makeup of the nucleic acid DNA cell lung cancer and skin cancer, and identified the changes that occur to make the cells cancerous, and in the case of lung cancer, scientists recorded more than 23 genetic mutation, and in skin cancer scientists scored more than 33 genetically mutated cells to drive the growth of non – normal.

On the other hand, the Times newspaper described the move as possible to occur scientific revolution through which the targeting of the disease in each person separately. Pointing out that scientists forecast that by 2020 all cancer patients will be able to analyze the disease have access to genetic defects that lead to, and can use this information later to choose the most effective treatment.

As explained in The Times that such disclosure would lead to the development of effective drugs to target the DNA errors that lead to disease and to highlight the ways in which to prevent it.